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SUMMARY Sexually transmitted diseases and infections (STDIs) 
have for centuries been a big concern all around the world. Since 
they were recognized, many groups have thought how to provide 
care for those affected with STDIs. They are most prevalent among 
teenagers and young adults. Nearly two-thirds of all STDIs occur 
in people younger than 25 years. The incidence of STDIs is rising. 
STDIs exist in three different forms, viral, bacterial, and parasitic. 
Screening is recommended in all young people who may have been 
sexually abused or who have been found to have an STDI. Risk 
prevention must not be a singular occasion but continuous task. 
Preventive and curative medical measures must be combined with 
social and psychological assistance. The prevention and counseling 
methods together with effective public education are recommended 
to decrease the spread of STDIs.
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INTRODUCTION
 Sexually transmitted diseases and infections 
(STDIs) have for centuries been a big concern all 
around the world. Since they were recognized, 
many groups have thought how to provide care for 
those affected with STDIs. They affect men and 
women of all backgrounds and economic levels. 
More than 20 STDIs have now been identified, 
and they affect more and more men and wom-
en all over the world each year. They are most 
prevalent among teenagers and young adults. 
Nearly two-thirds of all STDIs occur in people 
younger than 25 years. The incidence of STDIs 
is rising, in part because in the last few decades 
young people have become sexually active ear-
lier. Sexually active people today are more likely 
to have multiple sex partners during their lives 
and are potentially at a risk of developing STDIs. 
 Most of the time, STDIs cause no symptoms, 
particularly in women. When and if symptoms de-
velop, they may be confused with those of other 
diseases not transmitted through sexual contact. 
Even when an STDI causes no symptoms, how-
ever, a person who is infected may be able to pass 
the disease on to a sex partner. That is why many 
doctors recommend periodic testing or screening 
for people who have more than one sex partner.
 According to the World Health Organization 
(WHO), there are at least 250 million new cases 
of STDI s every year in the world. This is made up 
of 120 million with trichomoniasis, 50 million with 
genital chlamydia, 30 million with genital papillo-
mavirus (implicated in cervical cancer), 25 million 
with gonorrhea, 20 million with genital herpes, 3.5 
million with syphilis, 2 million with chancroid, and 




perhaps 2 million new cases of HIV annually. In 
Europe, STDIs are now second only to chest and 
throat infections as a cause of illness due to infec-
tion. Therefore doctors of various kinds (general 
practitioners, venereologist or dermatovenereolo-
gists, urologists, gynecologists) and some nurses 
have engaged in treating STDIs. Any care provid-
ed should be based on evidence and, to ensure a 
uniform high standard of evidence-based care, it is 
wise to follow national or regional guidelines. It is 
important to recognize the risk groups for STDIs. 
STDIs exist in three different forms, viral, bacte-
rial, and parasitic. Syphilis, gonorrhea, chancroid, 
lymphogranuloma venereum and granuloma in-
guinale were considered the five “classic” veneral 
diseases. The strategy for gonococcal infections 
is a 25% reduction by 2007. 
WHAT IS KNOWN ABOUT STDIs
 Viral STDs are with one for life and there is 
no cure yet. Herpes simplex is the most common 
cause of genital ulceration in developed countries. 
Approximately 90% of genital herpes infections 
are caused by type 2 herpes virus (HSV-2). Five 
to 30% of all first-case episodes may be second-
ary to herpes simplex type 1, while most cases of 
recurrent herpes are secondary to HSV-2. 
Genital human papillomavirus (HPV) is one of the 
most common causes of sexually transmitted dis-
ease in both men and women, and it has been 
identified as a significant risk factor for the devel-
opment of dysplasia and cancer. HPV infections 
may be latent, subclinical or clinical. There are 
different HPV types that can cause infection, and 
according to malignant potential there are high-
risk and low-risk types. In most individuals the in-
fection will disappear within few months after the 
first exposure. Several factors such as immunity, 
smoking, and hormone factors may influence the 
natural history of HPV infection. It usually takes 
many years for a HPV infection occurring in the 
late teens or early 20s to progress to precancer 
peaking at 30 years of age. Male genital HPV in-
fection is of particular importance since it is often 
asymptomatic. The diagnosis and therapy of HPV 
infections in men are often of potential benefit be-
cause they may decrease the reservoir of virus 
from which cervical intraepithelial neoplasia (CIN) 
lesions may arise in women. 
 Both hepatitis B and C viruses are common 
causes of persistent hepatitis and chronic liver 
disease. Beyond liver dysfunction, chronic in-
volvement may lead to several extrahepatic and 
dermatologic manifestations. Although the two vi-
ruses are commonly transmitted by other routes, 
sexual transmission is becoming ever more rec-
ognized as a significant source of exposure. The 
expected uptake of the full 3 doses of hepatitis B 
vaccine in homosexual/bisexual men not naturally 
immune or previously immunized is to be 70% by 
December 2006.
 The most deadly of all STDIs would be acquired 
immunodeficiency syndrome (AIDS). The spread 
of sexually transmitted AIDS increased dramati-
cally during the 1980s and continued through the 
1990s. Other STDIs are often seen in tandem 
with AIDS, partly because open sores that they 
produce can provide an easy route for the AIDS 
virus to enter the body. Experts believe that hav-
ing STDIs other than AIDS increases one’s risk for 
becoming infected with the AIDS virus. The effects 
of HIV testing for new attendees at clinics by 2005 
can take us to 80% and it is estimated that reduc-
tion of newly acquired HIV infection by 2007 can 
be 25%. 
 Pelvic inflammatory disease is very common 
and accounts for up to 20% of all gynecology con-
sultations. The damage from internal infection can 
produce a wide variety of chronic or acute symp-
toms, resulting in infertility amongst other things, 
and sometimes life-threatening pregnancies out-
side the womb. It can be caused by Ureaplasma 
urealyticum/Mycoplasma hominis, Chlamydia tra-
chomatis, and many other organisms.
 Seventy to 80% of all cases of nongonococcal 
urethritis (NGU) are associated with Chlamydia 
trachomatis and/or Ureaplasma urealyticum/My-
coplasma hominis. The major complication of 
NGU is epididymitis and mucopurulent cervicitis, 
acute pelvic inflammatory disease, infertility or 
complicated pregnancy and transmission to neo-
nate if the birth canal is infected.
 Trichomonas vaginalis may infect as many as 
10%-20% of sexually active men and women. In 
women it causes infection of the vagina and ure-
thra with profuse, thin, foamy, yellowish discharge 
with local burning and itching that may extend 
to involve the adjacent skin. There is recent evi-
dence for a possible relationship between vaginal 
trichomoniasis and adverse pregnancy outcomes, 
such as preterm labor, premature rupture of mem-
branes, and postabortal/postcesarean infection.
 The yeasts like fungus Candida albicans can 
normally be found on mucous membranes, skin, in 
the gastrointestinal tract, and vaginal vault. Under 
certain circumstances, it transforms to a pathogen 
and can cause localized (vulvovaginitis, balano-
posthitis) or generalized mucocutaneous diseases. 
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 Parasitic STD infections are pediculosis and 
scabies, sometimes epidemiologically very impor-
tant STDIs.
 Some infections have become resistant to the 
drugs used to treat them and now require newer 
types of antibiotics. Although some STDIs can be 
easily treated, there is no cure for other infections. 
Some infections, for example-HIV and hepatitis B, 
can have serious health sequels.
METHODS OF CARE FOR AN ADE-
QUATE SERVICE OF STDIs
 The risk of acquiring an STDI also increases 
with the number of partners over lifetime. Any-
one who is sexually active should 1) have regu-
lar check-ups for STDIs, even in the absence of 
symptoms and especially if having sex with a new 
partner. These tests can be done during a routine 
visit to the doctor’s office; 2) learn the common 
symptoms of STDIs; 3) seek medical help imme-
diately if any suspect symptoms develop, even if 
they are mild; and 4) avoid having sex during men-
struation. Anyone diagnosed as having an STDI 
should 1) be treated to reduce the risk of trans-
mitting the STDI to an infant; 2) discuss with the 
doctor the possible risk of transmission in breast 
milk and whether to substitute it with a commercial 
formula; 3) notify all recent sex partners and urge 
them to get a check-up; 4) follow the doctor’s in-
structions and complete full course of medication 
prescribed; 5) a follow-up test to ensure that the 
infection has been cured is often an important step 
in treatment; and 5) avoid all sexual activity while 
being treated for STDI. 
 The knowledge about STDIs varies consider-
ably depending on the disease and the country. 
People are more aware of life-threatening STDIs 
such as HIV/AIDS, and less knowledgeable about 
STDIs worldwide. It is necessary to provide sever-
al factors such as an adequate level of knowledge 
about STDIs, a positive attitude to a healthy life-
style, and modification of sexual behavior in order 
to lower the incidence of STDIs.
 Using the national societies that do exist and 
the WHO, it might be possible to move the mat-
ter of STDIs further up across the wider Europe. 
Where sexual abuse is suspected or disclosed, 
the clinician must work with infected persons to 
support them and address the possible sequel 
of STDIs, pregnancy, psychological, and psy-
chosexual issues. Screening is recommended in 
all young people who may have been sexually 
abused or who have been found to have an STDI. 
Risk prevention must not be a singular occasion 
but continuous task. Preventive and curative med-
ical measures must be combined with social and 
psychological assistance. Methods and equipment 
for microbiologic and serologic testing must meet 
high professional standards. The prevention and 
counseling methods together with effective pub-
lic education are recommended to decrease the 
spread of STDIs. Future advances are expected 
with better therapies for viral STDs and vaccines 
for several STDs. 
References
1. Bingam JS. Services for sexually transmitted infec-
tions in the new millennium – some thoughts from 
the UK. Acta Dermatovenerol Croat 2002;10:234-9.
2. Bingam JS. Sexually transmitted infections in west-
ern Europe-from the North Cape to the Black Sea. 
Int J STD AIDS 2001;12:811-2.
3. Dehne KL, Riedner G, Neckermann C, Mykyer O, 
Ndowa FJ,  et al. A survey of STI policies and pro-
grammes in the European region: preliminary re-
sults. Sex Transm Infect 2002;78:380-4.
4. Public Health Laboratory Service. Trends in sexu-
ally transmitted infections in the United Kingdom, 
1991 to 2000. London: Public Health Laboratory 
Service, 2001.
5. Nicoll A, Hamers F. Are trends in HIV, gonorrhoea 
and syphilis worsening in western Europe? Br Med 
J 2002;324:1324-7.
6. Adler MW, Meheus AZ. Epidemiology of sexually 
transmitted infections and human immunodeficien-
cy virus in Europe. J Eur Acad Dermatol Venereol 
2000:14:370-7.
7. World Health Organisation Europe STI task Force. 
Overview of HIV/AIDS/STI situation in the Europe-
an Region. www.sti-taskforce.org (accessed 22 July 
2002).
    Acta Dermatovenerol Croat
News and Comments  2005;13(2):127-129
129
